CONTRACT PHARMACEUTICAL MANUFACTURING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Global contract pharmaceutical manufacturing market is estimated to be valued at USD 232.28 Bn in 2025, and is expected to exhibit a CAGR of 9.9% during the forecast period (2025-2032). The global contract pharmaceutical manufacturing market has been witnessing steady growth over the past few years. Contract pharmaceutical manufacturing refers to the outsourcing of certain pharmaceutical processes such as manufacturing, packaging, and testing of pharmaceutical drugs to a third party company known as contract manufacturing organizations (CMOs). The growing need to reduce manufacturing costs and focus on core competencies are some of the key factors driving pharmaceutical companies to outsource their production requirements to CMOs. In addition, continued patent cliff losses, rising demand for generic drugs, and increasing outsourcing of drug development and commercialization activities are further expected to support the growth of the global contract pharmaceutical manufacturing market in the coming years.

Market Dynamics:

The global contract pharmaceutical manufacturing market growth is driven by rising incidence of cardiovascular diseases and increasing elderly population base globally who are at high risk of arrhythmias. According to the data by World Health Organization, cardiovascular diseases are the leading cause of deaths worldwide with over 17 million lives lost each year due to heart attacks and strokes. Moreover, technological innovations with focus on miniaturization and battery longevity have expanded indications for pacemaker implants. However, high costs associated with pacemaker procedures and risk of device complications such as lead defects and infections can hamper the market growth.

Key Features of the Study:

• This report provides an in-depth analysis of the global contract pharmaceutical manufacturing market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global contract pharmaceutical manufacturing market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Lonza Group, Boehringer Ingelheim GmbH, Genpact Limited, Accenture plc, Quintiles Transnational Corporation, Baxter , Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma, Pfizer, Inc., The Almac Group, Teva Pharmaceutical Industries Ltd., Piramal Enterprises Ltd., Covance, Inc., Catalent, Inc., Abbvie, Inc., and Celltrion.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global contract pharmaceutical manufacturing market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contract pharmaceutical manufacturing market.

Detailed Segmentation-

• By Service Type:
  • Contract Manufacturing Organization (CMO)
    • API Manufacturing
    • Final dosage form manufacturing
    • Packaging
  • Contract Research Organization (CRO)
    • Drug Discovery
    • Preclinical Studies
    • Early Phase I – IIa
    • Phase IIa – III
    • Phase IIIb – IV
    • Medical Coding and Writing
    • Monitoring
    • Clinical Data Management
    • Others (Protocol Development, etc.)
• By Molecule Type:
  • Small Molecule
  • Large Molecule
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

Company Profiles:

• Lonza Group
• Boehringer Ingelheim GmbH
• Genpact Limited
• Accenture plc
• Quintiles Transnational Corporation
• Baxter 
• Reddy’s Laboratories Ltd.
• Aurobindo Pharma
• Pfizer, Inc.
• The Almac Group
• Teva Pharmaceutical Industries Ltd.
• Piramal Enterprises Ltd.
• Covance, Inc.
• Catalent, Inc.
• Abbvie, Inc.
• Celltrion